Version 5.4
| Bos taurus Gene: PPP2R5E | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Summary | |||||||||
| InnateDB Gene | IDBG-646763.3 | ||||||||
| Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||
| Gene Symbol | PPP2R5E | ||||||||
| Gene Name | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform | ||||||||
| Synonyms | |||||||||
| Species | Bos taurus | ||||||||
| Ensembl Gene | ENSBTAG00000019784 | ||||||||
| Encoded Proteins |
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform
|
||||||||
| Protein Structure |
|
||||||||
| Useful resources | Stemformatics EHFPI ImmGen | ||||||||
| Entrez Gene | |||||||||
| Summary |
This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000154001:
The product of this gene belongs to the phosphatase 2A regulatory subunit B family. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes an epsilon isoform of the regulatory subunit B56 subfamily. [provided by RefSeq, Jul 2008] The protein encoded by this gene belongs to the phosphatase 2A regulatory subunit B family. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes an epsilon isoform of the regulatory subunit B56 subfamily. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2013] |
||||||||
| Gene Information | |||||||||
| Type | Protein coding | ||||||||
| Genomic Location | Chromosome 10:75953664-76109267 | ||||||||
| Strand | Reverse strand | ||||||||
| Band | |||||||||
| Transcripts |
|
||||||||
| Interactions | |||||||||
| Number of Interactions |
This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 24 interaction(s) predicted by orthology.
|
||||||||
| Gene Ontology | |||||||||
Molecular Function |
|
||||||||
| Biological Process |
|
||||||||
| Cellular Component |
|
||||||||
| Orthologs | |||||||||
|
Species
Homo sapiens
Mus musculus
|
Gene ID
Gene Order
|
||||||||
| Pathways | |||||||||
| NETPATH | |||||||||
| REACTOME |
APC truncation mutants have impaired AXIN binding pathway
Signaling by Wnt pathway
Signaling by WNT in cancer pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
M Phase pathway
Costimulation by the CD28 family pathway
Separation of Sister Chromatids pathway
TCF dependent signaling in response to WNT pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
Mitotic Metaphase and Anaphase pathway
Mitotic Anaphase pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
Immune System pathway
Cell Cycle, Mitotic pathway
truncations of AMER1 destabilize the destruction complex pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
Beta-catenin phosphorylation cascade pathway
CTLA4 inhibitory signaling pathway
Cell Cycle pathway
Signal Transduction pathway
AXIN missense mutants destabilize the destruction complex pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
disassembly of the destruction complex and recruitment of AXIN to the membrane pathway
TCF7L2 mutants don't bind CTBP pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
AMER1 mutants destabilize the destruction complex pathway
Resolution of Sister Chromatid Cohesion pathway
Adaptive Immune System pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
Mitotic Prometaphase pathway
APC truncation mutants are not K63 polyubiquitinated pathway
Disease pathway
Degradation of beta-catenin by the destruction complex pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
truncated APC mutants destabilize the destruction complex pathway
|
||||||||
| KEGG | |||||||||
| INOH | |||||||||
| PID NCI | |||||||||
| Pathway Predictions based on Human Orthology Data | |||||||||
| NETPATH | |||||||||
| REACTOME |
Resolution of Sister Chromatid Cohesion pathway
Mitotic Prometaphase pathway
Separation of Sister Chromatids pathway
CTLA4 inhibitory signaling pathway
Costimulation by the CD28 family pathway
Platelet sensitization by LDL pathway
Platelet homeostasis pathway
Beta-catenin phosphorylation cascade pathway
Degradation of beta-catenin by the destruction complex pathway
truncated APC mutants destabilize the destruction complex pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
APC truncation mutants are not K63 polyubiquitinated pathway
AMER1 mutants destabilize the destruction complex pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
Signaling by WNT in cancer pathway
AXIN missense mutants destabilize the destruction complex pathway
Signaling by Wnt pathway
disassembly of the destruction complex and recruitment of AXIN to the membrane pathway
APC truncation mutants have impaired AXIN binding pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
Signal Transduction pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
Cell Cycle pathway
Adaptive Immune System pathway
Immune System pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
truncations of AMER1 destabilize the destruction complex pathway
M Phase pathway
Mitotic Anaphase pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
TCF dependent signaling in response to WNT pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
Cell Cycle, Mitotic pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
TCF7L2 mutants don't bind CTBP pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
Disease pathway
Hemostasis pathway
Mitotic Metaphase and Anaphase pathway
Cell Cycle, Mitotic pathway
Disease pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
Signaling by Wnt pathway
Separation of Sister Chromatids pathway
Resolution of Sister Chromatid Cohesion pathway
Beta-catenin phosphorylation cascade pathway
Signaling by WNT in cancer pathway
Degradation of beta-catenin by the destruction complex pathway
AMER1 mutants destabilize the destruction complex pathway
Cell Cycle pathway
Immune System pathway
M Phase pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
APC truncation mutants have impaired AXIN binding pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
disassembly of the destruction complex and recruitment of AXIN to the membrane pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
AXIN missense mutants destabilize the destruction complex pathway
TCF dependent signaling in response to WNT pathway
Costimulation by the CD28 family pathway
Mitotic Metaphase and Anaphase pathway
Mitotic Prometaphase pathway
APC truncation mutants are not K63 polyubiquitinated pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
TCF7L2 mutants don't bind CTBP pathway
CTLA4 inhibitory signaling pathway
Adaptive Immune System pathway
truncations of AMER1 destabilize the destruction complex pathway
Signal Transduction pathway
truncated APC mutants destabilize the destruction complex pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
Mitotic Anaphase pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
|
||||||||
| KEGG |
Oocyte meiosis pathway
mRNA surveillance pathway pathway
Oocyte meiosis pathway
mRNA surveillance pathway pathway
|
||||||||
| INOH |
Insulin receptor signaling pathway
GPCR Dopamine D1like receptor signaling pathway pathway
Insulin receptor signaling pathway
GPCR Dopamine D1like receptor signaling pathway pathway
|
||||||||
| PID NCI | |||||||||
| Cross-References | |||||||||
| SwissProt | A4FV68 | ||||||||
| TrEMBL | |||||||||
| UniProt Splice Variant | |||||||||
| Entrez Gene | 533617 | ||||||||
| UniGene | Bt.23994 | ||||||||
| RefSeq | NM_001083468 XM_005211993 XM_005211994 | ||||||||
| HUGO | |||||||||
| OMIM | |||||||||
| CCDS | |||||||||
| HPRD | |||||||||
| IMGT | |||||||||
| EMBL | BC123807 | ||||||||
| GenPept | AAI23808 | ||||||||
| RNA Seq Atlas | 533617 | ||||||||